Nektar Therapeutics NKTR
NASDAQ NKTR
$59.29 -1.11 (-1.84%)
As of: Sep 29, 2026 · 3:59 PM EDT

Nektar Therapeutics (NKTR) Operating Margin (2010 - 2026)

Updated

Nektar Therapeutics (NKTR) recorded Operating Margin of -417.94% in Q2 2026, down 93.73 percentage points from -324.21% a year earlier and down 58.35 percentage points from the prior quarter.

Analysis

Nektar Therapeutics (NKTR) Operating Margin (2010 - 2026) Analysis & Trends

On a TTM basis, Nektar Therapeutics' Operating Margin came in at -257.80% as of Jun 30, 2026, down 123.34 percentage points year-over-year; for FY2025, it came in at -253.66%, down 146.78 percentage points from FY2024.

  • Annual Operating Margin has a five-year change of +24.34 percentage points (FY2020 to FY2025).
  • Across earlier years, Operating Margin came in at -106.88% in FY2024 (+185.71 pp), -292.59% in FY2023 (+116.05 pp), -408.63% in FY2022 (+29.12 pp) and -437.76% in FY2021 (-159.75 pp).
  • The Q2 2026 figure is the lowest quarterly Operating Margin since Q1 2025.
  • On a year-over-year basis, Operating Margin rose in three of the last eight quarters, with an average year-over-year change of -58.91 percentage points.
  • Peak year-over-year performance for Operating Margin in the last five years was a gain of 461.23 percentage points in Q2 2023, against a drop of 319.06 percentage points in Q2 2022 at the low end.
  • Per Business Quant, the preceding three quarters came in at -359.58% (Q1 2026), -126.86% (Q4 2025) and -268.63% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Operating Margin (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 28.21%
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 37.86%
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn -3.52%
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 32.97%
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 20.57%
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 34.95%
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn -133.21%
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 28.37%
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 37.40%
10 Nektar Therapeutics 2.00 Bn 227.61 Mn - -417.94%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -417.94%
Mar 31, 2026 -359.58%
Dec 31, 2025 -126.86%
Sep 30, 2025 -268.63%
Jun 30, 2025 -324.21%
Mar 31, 2025 -425.76%
Dec 31, 2024 49.18%
Sep 30, 2024 -142.37%
Jun 30, 2024 -211.90%
Mar 31, 2024 -163.72%
Dec 31, 2023 -140.30%
Sep 30, 2023 -185.82%
Jun 30, 2023 -246.84%
Mar 31, 2023 -623.83%
Dec 31, 2022 -238.25%
Sep 30, 2022 -229.85%
Jun 30, 2022 -708.07%
Mar 31, 2022 -469.58%
Dec 31, 2021 -451.48%
Sep 30, 2021 -455.82%
API Access

Nektar Therapeutics Operating Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-margin&ticker=NKTR&period=max&api_key=YOUR_API_KEY